- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge revenues sag in second quarter
Merge revenues sag in second quarterMerge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).Revenues were $1.9 million, compared with
Merge revenues sag in second quarter
Merge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).
Revenues were $1.9 million, compared with $2.1 million in 1997. The company posted a net loss of $683,000, compared with net income of $247,000 in the same period last year.
Merge executives believe the decrease in end-user sales is a temporary dip, and the company is deploying additional resources to reach more of its target audience in the U.S. and Europe. The company's sales through OEMs and value-added resellers performed as expected.
In other Merge news, the company began shipments of its MergeARK low-cost archiving offering last month. MergeARK supports online storage via redundant arrays of inexpensive disks (RAID) as well as CD-R media.
- Search again
- Homepage
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
